Cargando…

Facial and Oral Manifestations Following COVID-19 Vaccination: A Survey-Based Study and a First Perspective

(1) Background: Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) emerged in Wuhan, China, in late 2019. The development of effective and safe vaccines against SARS-CoV-2 has been extremely fast. The list of orofacial adverse effects of BNT162b2 and mRNA-1273 vaccines based on the clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazur, Marta, Duś-Ilnicka, Irena, Jedliński, Maciej, Ndokaj, Artnora, Janiszewska-Olszowska, Joanna, Ardan, Roman, Radwan-Oczko, Malgorzata, Guerra, Fabrizio, Luzzi, Valeria, Vozza, Iole, Marasca, Roberto, Ottolenghi, Livia, Polimeni, Antonella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125066/
https://www.ncbi.nlm.nih.gov/pubmed/34066995
http://dx.doi.org/10.3390/ijerph18094965
_version_ 1783693390927364096
author Mazur, Marta
Duś-Ilnicka, Irena
Jedliński, Maciej
Ndokaj, Artnora
Janiszewska-Olszowska, Joanna
Ardan, Roman
Radwan-Oczko, Malgorzata
Guerra, Fabrizio
Luzzi, Valeria
Vozza, Iole
Marasca, Roberto
Ottolenghi, Livia
Polimeni, Antonella
author_facet Mazur, Marta
Duś-Ilnicka, Irena
Jedliński, Maciej
Ndokaj, Artnora
Janiszewska-Olszowska, Joanna
Ardan, Roman
Radwan-Oczko, Malgorzata
Guerra, Fabrizio
Luzzi, Valeria
Vozza, Iole
Marasca, Roberto
Ottolenghi, Livia
Polimeni, Antonella
author_sort Mazur, Marta
collection PubMed
description (1) Background: Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) emerged in Wuhan, China, in late 2019. The development of effective and safe vaccines against SARS-CoV-2 has been extremely fast. The list of orofacial adverse effects of BNT162b2 and mRNA-1273 vaccines based on the clinical trials are reported to be rare. The aim of this study was to investigate the facial and oral manifestations of COVID-19 vaccination using a survey-based study. (2) Methods: The questionnaire was developed using Google Forms and sent anonymously to a total of 700 subjects (medical personnel) in Poland, Italy, and other EU countries. (3) Results: 223 people answered the questionnaire, mainly vaccinated with BNT162b2. Only 3.1% and 5.4% experienced oral and facial symptoms, respectively. General diseases presence and age have significant influence on the probability of oral symptoms occurrence after the second dose. Facial symptoms are correlated with general disease; autoimmune pathologies and age, at first and second dose, respectively. Gender, smoking and regular medication intake have significant influence on the probability of taking an absence day. Gender, age, and smoking have a significant influence on the duration of symptoms after second dose. (4) Conclusions: Based on the results of this preliminary survey, there is no observed significant correlation between vaccine administration for COVID-19 and facial and oral manifestations.
format Online
Article
Text
id pubmed-8125066
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81250662021-05-17 Facial and Oral Manifestations Following COVID-19 Vaccination: A Survey-Based Study and a First Perspective Mazur, Marta Duś-Ilnicka, Irena Jedliński, Maciej Ndokaj, Artnora Janiszewska-Olszowska, Joanna Ardan, Roman Radwan-Oczko, Malgorzata Guerra, Fabrizio Luzzi, Valeria Vozza, Iole Marasca, Roberto Ottolenghi, Livia Polimeni, Antonella Int J Environ Res Public Health Article (1) Background: Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) emerged in Wuhan, China, in late 2019. The development of effective and safe vaccines against SARS-CoV-2 has been extremely fast. The list of orofacial adverse effects of BNT162b2 and mRNA-1273 vaccines based on the clinical trials are reported to be rare. The aim of this study was to investigate the facial and oral manifestations of COVID-19 vaccination using a survey-based study. (2) Methods: The questionnaire was developed using Google Forms and sent anonymously to a total of 700 subjects (medical personnel) in Poland, Italy, and other EU countries. (3) Results: 223 people answered the questionnaire, mainly vaccinated with BNT162b2. Only 3.1% and 5.4% experienced oral and facial symptoms, respectively. General diseases presence and age have significant influence on the probability of oral symptoms occurrence after the second dose. Facial symptoms are correlated with general disease; autoimmune pathologies and age, at first and second dose, respectively. Gender, smoking and regular medication intake have significant influence on the probability of taking an absence day. Gender, age, and smoking have a significant influence on the duration of symptoms after second dose. (4) Conclusions: Based on the results of this preliminary survey, there is no observed significant correlation between vaccine administration for COVID-19 and facial and oral manifestations. MDPI 2021-05-07 /pmc/articles/PMC8125066/ /pubmed/34066995 http://dx.doi.org/10.3390/ijerph18094965 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mazur, Marta
Duś-Ilnicka, Irena
Jedliński, Maciej
Ndokaj, Artnora
Janiszewska-Olszowska, Joanna
Ardan, Roman
Radwan-Oczko, Malgorzata
Guerra, Fabrizio
Luzzi, Valeria
Vozza, Iole
Marasca, Roberto
Ottolenghi, Livia
Polimeni, Antonella
Facial and Oral Manifestations Following COVID-19 Vaccination: A Survey-Based Study and a First Perspective
title Facial and Oral Manifestations Following COVID-19 Vaccination: A Survey-Based Study and a First Perspective
title_full Facial and Oral Manifestations Following COVID-19 Vaccination: A Survey-Based Study and a First Perspective
title_fullStr Facial and Oral Manifestations Following COVID-19 Vaccination: A Survey-Based Study and a First Perspective
title_full_unstemmed Facial and Oral Manifestations Following COVID-19 Vaccination: A Survey-Based Study and a First Perspective
title_short Facial and Oral Manifestations Following COVID-19 Vaccination: A Survey-Based Study and a First Perspective
title_sort facial and oral manifestations following covid-19 vaccination: a survey-based study and a first perspective
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125066/
https://www.ncbi.nlm.nih.gov/pubmed/34066995
http://dx.doi.org/10.3390/ijerph18094965
work_keys_str_mv AT mazurmarta facialandoralmanifestationsfollowingcovid19vaccinationasurveybasedstudyandafirstperspective
AT dusilnickairena facialandoralmanifestationsfollowingcovid19vaccinationasurveybasedstudyandafirstperspective
AT jedlinskimaciej facialandoralmanifestationsfollowingcovid19vaccinationasurveybasedstudyandafirstperspective
AT ndokajartnora facialandoralmanifestationsfollowingcovid19vaccinationasurveybasedstudyandafirstperspective
AT janiszewskaolszowskajoanna facialandoralmanifestationsfollowingcovid19vaccinationasurveybasedstudyandafirstperspective
AT ardanroman facialandoralmanifestationsfollowingcovid19vaccinationasurveybasedstudyandafirstperspective
AT radwanoczkomalgorzata facialandoralmanifestationsfollowingcovid19vaccinationasurveybasedstudyandafirstperspective
AT guerrafabrizio facialandoralmanifestationsfollowingcovid19vaccinationasurveybasedstudyandafirstperspective
AT luzzivaleria facialandoralmanifestationsfollowingcovid19vaccinationasurveybasedstudyandafirstperspective
AT vozzaiole facialandoralmanifestationsfollowingcovid19vaccinationasurveybasedstudyandafirstperspective
AT marascaroberto facialandoralmanifestationsfollowingcovid19vaccinationasurveybasedstudyandafirstperspective
AT ottolenghilivia facialandoralmanifestationsfollowingcovid19vaccinationasurveybasedstudyandafirstperspective
AT polimeniantonella facialandoralmanifestationsfollowingcovid19vaccinationasurveybasedstudyandafirstperspective